Lactose (India) Ltd | 126 Cr. | 100 | 247/84.3 | 24.5 | 46.7 | 0.00 % | 12.9 % | 9.75 % | 10.0 |
MPS Pharmaa Ltd | 4.59 Cr. | 2.40 | 4.33/2.40 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
Gujarat Themis Biosyn Ltd | 2,663 Cr. | 244 | 390/192 | 50.6 | 20.5 | 0.27 % | 45.0 % | 33.8 % | 1.00 |
Gujarat Terce Laboratories Ltd | 35.2 Cr. | 47.5 | 94.9/46.3 | | 8.73 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 30.8 Cr. | 21.0 | 29.1/13.1 | 30.2 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
Godavari Drugs Ltd | 62.5 Cr. | 83.0 | 155/79.0 | 14.3 | 57.6 | 0.00 % | 10.3 % | 10.6 % | 10.0 |
Glenmark Life Sciences Ltd | 56,978 Cr. | 2,020 | 2,286/1,275 | 43.2 | 314 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
Gennex Laboratories Ltd | 280 Cr. | 12.3 | 29.0/11.2 | 17.4 | 8.21 | 0.00 % | 12.5 % | 9.03 % | 1.00 |
Ganga Pharmaceuticals Ltd | 7.06 Cr. | 14.6 | 27.1/9.25 | 88.2 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
Fredun Pharmaceuticals Ltd | 500 Cr. | 1,059 | 1,143/635 | 21.3 | 299 | 0.07 % | 18.9 % | 15.8 % | 10.0 |
Fervent Synergies Ltd | 116 Cr. | 23.1 | 32.0/15.0 | 35.4 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
Fermenta Biotech Ltd | 999 Cr. | 339 | 449/219 | 12.4 | 123 | 0.74 % | 23.0 % | 24.7 % | 5.00 |
Fabino Enterprises Ltd | 5.46 Cr. | 26.0 | 39.0/22.8 | 42.0 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
Evoq Remedies Ltd | 9.61 Cr. | 3.86 | 9.54/2.11 | 107 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
Everest Organics Ltd | 308 Cr. | 317 | 477/112 | 49.6 | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
Entero Healthcare Solutions Ltd | 5,611 Cr. | 1,289 | 1,584/1,078 | 59.2 | 396 | 0.00 % | 8.72 % | 5.64 % | 10.0 |
Murae Organisor Ltd | 151 Cr. | 0.74 | 1.24/0.48 | 20.0 | 1.02 | 0.00 % | 4.21 % | 5.69 % | 1.00 |
Dipna Pharmachem Ltd | 48.6 Cr. | 20.2 | 26.3/6.40 | 50.1 | 16.0 | 0.00 % | 6.11 % | 2.55 % | 10.0 |
Decipher Labs Ltd | 11.1 Cr. | 11.0 | 18.9/9.61 | | 22.6 | 0.00 % | 28.4 % | 22.7 % | 10.0 |
Coral Laboratories Ltd | 202 Cr. | 567 | 999/561 | 8.19 | 563 | 0.35 % | 17.4 % | 13.1 % | 10.0 |
Concord Drugs Ltd | 54.7 Cr. | 54.7 | 67.0/26.1 | 182 | 34.1 | 0.00 % | 4.83 % | 0.88 % | 10.0 |
Colinz Laboratories Ltd | 20.1 Cr. | 44.0 | 88.7/37.9 | 41.9 | 20.7 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
Cian Healthcare Ltd | 8.02 Cr. | 3.21 | 19.5/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 21.6 Cr. | 144 | 154/58.3 | 63.5 | 87.6 | 0.00 % | 3.78 % | 2.62 % | 10.0 |
Checkpoint Trends Ltd | 23.9 Cr. | 43.7 | 45.4/6.08 | 265 | 1.02 | 0.00 % | 9.17 % | 5.50 % | 10.0 |
Chandra Bhagat Pharma Ltd | 41.5 Cr. | 55.0 | 85.5/0.00 | 48.3 | 39.7 | 0.00 % | 6.48 % | 2.92 % | 10.0 |
Brawn Biotech Ltd | 5.37 Cr. | 17.9 | 26.0/15.5 | | 11.2 | 0.00 % | 42.5 % | 42.8 % | 10.0 |
Blue Jet Healthcare Ltd | 13,899 Cr. | 801 | 1,028/455 | 38.8 | 65.3 | 0.12 % | 40.6 % | 30.8 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 92.4 Cr. | 21.4 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 9.82 Cr. | 19.4 | 46.0/17.4 | 42.7 | 18.7 | 0.00 % | 10.1 % | 6.30 % | 10.0 |
BDH Industries Ltd | 171 Cr. | 297 | 418/241 | 18.5 | 119 | 1.51 % | 17.8 % | 14.2 % | 10.0 |
Bacil Pharma Ltd | 53.9 Cr. | 37.6 | 62.6/14.8 | 135 | 17.7 | 0.00 % | 3.05 % | 3.00 % | 10.0 |
Aurobindo Pharma Ltd | 61,075 Cr. | 1,042 | 1,593/994 | 18.0 | 557 | 0.43 % | 14.3 % | 11.2 % | 1.00 |
Auro Laboratories Ltd | 162 Cr. | 260 | 303/167 | 88.2 | 69.0 | 0.00 % | 3.79 % | 4.33 % | 10.0 |
Anuh Pharma Ltd | 903 Cr. | 90.5 | 123/74.0 | 21.8 | 32.5 | 1.66 % | 17.2 % | 13.4 % | 5.00 |
ANG Lifesciences India Ltd | 39.2 Cr. | 30.1 | 62.8/21.0 | | 51.2 | 0.00 % | 4.12 % | 14.4 % | 10.0 |
Acutaas Chemicals Ltd | 10,485 Cr. | 1,281 | 1,379/600 | 55.5 | 160 | 0.12 % | 19.9 % | 16.0 % | 5.00 |
Amerise Biosciences Ltd | 4.56 Cr. | 0.69 | 1.45/0.62 | 91.2 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 232 Cr. | 30.2 | 69.8/30.0 | 26.8 | 18.3 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
Adline Chem Lab Ltd | 9.61 Cr. | 16.4 | 26.0/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 109 Cr. | 4.63 | 6.25/2.82 | 198 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
Abbott India Ltd | 69,434 Cr. | 32,720 | 37,000/25,260 | 49.1 | 1,992 | 1.46 % | 46.2 % | 35.7 % | 10.0 |
Aarti Pharmalabs Ltd | 7,654 Cr. | 846 | 972/521 | 28.1 | 220 | 0.30 % | 17.4 % | 14.5 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 189 Cr. | 65.6 | 75.8/31.3 | 46.9 | 48.8 | 0.00 % | 6.00 % | 2.96 % | 10.0 |
Zota Health Care Ltd | 3,580 Cr. | 1,203 | 1,305/535 | | 78.1 | 0.08 % | 17.0 % | 36.0 % | 10.0 |
Wockhardt Ltd | 23,961 Cr. | 1,472 | 1,870/894 | | 268 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
Wanbury Ltd | 837 Cr. | 255 | 330/154 | 19.5 | 18.1 | 0.00 % | 34.9 % | 70.0 % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.11 % | % | 2.00 |
Venus Remedies Ltd | 642 Cr. | 489 | 568/270 | 13.7 | 420 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
Unichem Laboratories Ltd | 3,511 Cr. | 499 | 950/492 | 28.1 | 348 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
TTK Healthcare Ltd | 1,638 Cr. | 1,153 | 1,923/991 | 24.3 | 754 | 0.87 % | 9.26 % | 6.89 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,20,882 Cr. | 3,572 | 3,790/2,886 | 59.9 | 224 | 0.90 % | 27.0 % | 26.5 % | 5.00 |
Themis Medicare Ltd | 1,008 Cr. | 110 | 317/101 | | 43.7 | 0.46 % | 10.4 % | 7.65 % | 1.00 |
Syncom Formulations (India) Ltd | 1,748 Cr. | 18.4 | 27.9/14.1 | 35.8 | 3.62 | 0.00 % | 18.7 % | 15.6 % | 1.00 |
Suven Pharmaceuticals Ltd | 27,473 Cr. | 1,079 | 1,360/597 | 98.5 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
Suven Life Sciences Ltd | 5,470 Cr. | 250 | 303/102 | | 5.04 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 3,80,691 Cr. | 1,587 | 1,960/1,553 | 33.2 | 301 | 1.01 % | 20.2 % | 16.9 % | 1.00 |
Solara Active Pharma Sciences Ltd | 2,595 Cr. | 581 | 886/441 | 106 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
SMS Pharmaceuticals Ltd | 1,995 Cr. | 224 | 398/175 | 29.2 | 75.9 | 0.18 % | 12.2 % | 11.0 % | 1.00 |
SMS Lifesciences India Ltd | 347 Cr. | 1,135 | 1,750/927 | 18.6 | 650 | 0.13 % | 11.8 % | 10.0 % | 10.0 |
Shilpa Medicare Ltd | 8,092 Cr. | 825 | 1,003/530 | 90.4 | 243 | 0.00 % | 7.94 % | 4.28 % | 1.00 |
Sequent Scientific Ltd | 4,206 Cr. | 168 | 241/111 | 139 | 28.1 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
Sanofi India Ltd | 12,006 Cr. | 5,219 | 7,600/4,146 | 33.7 | 340 | 2.24 % | 49.2 % | 47.2 % | 10.0 |
RPG Life Sciences Ltd | 3,882 Cr. | 2,343 | 2,977/1,772 | 37.5 | 321 | 0.85 % | 32.8 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 10,522 Cr. | 6,334 | 6,500/4,863 | 35.0 | 323 | 1.97 % | 45.0 % | 33.5 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 223 Cr. | 63.2 | 87.5/31.9 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
Pfizer Ltd | 22,710 Cr. | 4,975 | 6,453/3,701 | 35.4 | 922 | 0.70 % | 21.6 % | 16.4 % | 10.0 |
Par Drugs & Chemicals Ltd | 124 Cr. | 101 | 348/81.0 | 8.78 | 80.4 | 0.00 % | 19.5 % | 14.5 % | 10.0 |
Panacea Biotec Ltd | 2,524 Cr. | 413 | 582/133 | | 136 | 0.00 % | 4.68 % | 5.03 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 3,838 Cr. | 756 | 1,998/604 | 38.5 | 250 | 0.00 % | 8.02 % | 8.18 % | 10.0 |
Neuland Laboratories Ltd | 16,676 Cr. | 13,005 | 18,100/10,060 | 127 | 1,188 | 0.09 % | 18.7 % | 14.8 % | 10.0 |
Nectar Lifescience Ltd | 314 Cr. | 14.0 | 56.5/13.0 | | 42.6 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
Natco Pharma Ltd | 16,264 Cr. | 908 | 1,639/660 | 8.64 | 425 | 0.66 % | 32.8 % | 28.0 % | 2.00 |
Morepen Laboratories Ltd | 2,581 Cr. | 47.1 | 101/41.7 | 27.9 | 21.1 | 0.42 % | 15.1 % | 11.8 % | 2.00 |
Marksans Pharma Ltd | 9,551 Cr. | 211 | 359/168 | 25.1 | 54.4 | 0.38 % | 20.0 % | 16.8 % | 1.00 |
Mangalam Drugs and Organics Ltd | 124 Cr. | 78.7 | 145/65.5 | 17.9 | 93.9 | 0.00 % | 8.20 % | 4.76 % | 10.0 |
Lyka Labs Ltd | 374 Cr. | 105 | 177/90.2 | 49.9 | 29.0 | 0.00 % | 9.91 % | 9.21 % | 10.0 |
Lupin Ltd | 87,453 Cr. | 1,917 | 2,403/1,774 | 23.6 | 377 | 0.63 % | 21.3 % | 20.6 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,117 Cr. | 560 | 980/499 | 12.9 | 335 | 0.32 % | 17.6 % | 13.0 % | 10.0 |
Laurus Labs Ltd | 44,195 Cr. | 819 | 923/418 | 86.7 | 84.6 | 0.15 % | 9.47 % | 7.75 % | 2.00 |
Kwality Pharmaceuticals Ltd | 1,170 Cr. | 1,128 | 1,235/511 | 29.3 | 256 | 0.00 % | 18.3 % | 16.2 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 167 Cr. | 76.1 | 129/63.6 | | 67.8 | 0.00 % | 29.9 % | % | 10.0 |
Kopran Ltd | 757 Cr. | 157 | 370/155 | 21.7 | 107 | 1.91 % | 9.75 % | 7.64 % | 10.0 |
Kilitch Drugs (India) Ltd | 785 Cr. | 449 | 500/265 | 31.5 | 116 | 0.00 % | 17.3 % | 13.2 % | 10.0 |
Jubilant Pharmova Ltd | 17,539 Cr. | 1,101 | 1,310/802 | 36.2 | 393 | 0.45 % | 9.54 % | 9.50 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 26,476 Cr. | 1,694 | 2,030/1,303 | 38.7 | 221 | 0.92 % | 25.8 % | 20.1 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,732 Cr. | 260 | 328/140 | 40.6 | 36.1 | 0.91 % | 23.0 % | 18.6 % | 2.00 |
Ipca Laboratories Ltd | 35,123 Cr. | 1,384 | 1,758/1,168 | 41.5 | 274 | 0.30 % | 14.7 % | 12.8 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 2,744 Cr. | 93.5 | 108/57.5 | 26.0 | 57.5 | 0.84 % | 8.86 % | 6.13 % | 2.00 |
Ind-Swift Ltd | 84.6 Cr. | 15.6 | 34.7/12.0 | 10.8 | 74.3 | 0.00 % | 11.9 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 618 Cr. | 102 | 178/67.2 | 7.48 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
Indoco Remedies Ltd | 2,665 Cr. | 289 | 388/190 | | 111 | 0.51 % | 0.48 % | 7.00 % | 2.00 |
Hikal Ltd | 3,554 Cr. | 288 | 465/234 | 56.2 | 102 | 0.21 % | 9.87 % | 7.41 % | 2.00 |
Hester Biosciences Ltd | 1,679 Cr. | 1,974 | 2,786/1,243 | 45.0 | 369 | 0.36 % | 9.71 % | 9.18 % | 10.0 |
Gufic BioSciences Ltd | 3,649 Cr. | 364 | 504/285 | 52.2 | 60.0 | 0.03 % | 13.0 % | 12.3 % | 1.00 |
Granules India Ltd | 10,676 Cr. | 440 | 725/412 | 22.2 | 153 | 0.33 % | 15.1 % | 13.9 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 57,371 Cr. | 2,033 | 2,286/1,275 | 43.5 | 314 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 44,735 Cr. | 2,641 | 3,516/1,921 | 47.2 | 115 | 1.60 % | 63.2 % | 46.9 % | 10.0 |
Gland Pharma Ltd | 31,964 Cr. | 1,940 | 2,131/1,200 | 28.2 | 592 | 0.95 % | 15.8 % | 11.6 % | 1.00 |
FDC Ltd | 7,895 Cr. | 485 | 659/359 | 29.3 | 140 | 1.06 % | 16.4 % | 12.2 % | 1.00 |
ERIS Lifesciences Ltd | 23,462 Cr. | 1,722 | 1,910/1,097 | 60.6 | 210 | 0.43 % | 12.2 % | 12.9 % | 1.00 |
Dr Reddys Laboratories Ltd | 99,874 Cr. | 1,197 | 1,421/1,020 | 17.6 | 402 | 0.67 % | 22.7 % | 18.0 % | 1.00 |
Dishman Carbogen Amcis Ltd | 3,739 Cr. | 238 | 308/161 | | 372 | 0.00 % | 2.44 % | 0.34 % | 2.00 |
Cipla Ltd | 1,20,016 Cr. | 1,486 | 1,702/1,310 | 22.3 | 386 | 0.87 % | 22.7 % | 17.8 % | 2.00 |
Caplin Point Laboratories Ltd | 16,046 Cr. | 2,111 | 2,641/1,514 | 28.5 | 375 | 0.28 % | 25.8 % | 21.7 % | 2.00 |
Brooks Laboratories Ltd | 454 Cr. | 154 | 203/94.2 | | 33.3 | 0.00 % | 9.90 % | 12.2 % | 10.0 |
Bliss GVS Pharma Ltd | 1,872 Cr. | 177 | 191/105 | 17.6 | 99.7 | 0.28 % | 11.7 % | 8.36 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 71.4 Cr. | 43.5 | 92.0/40.4 | 127 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
Biocon Ltd | 45,854 Cr. | 343 | 406/291 | 113 | 180 | 0.15 % | 6.25 % | 4.76 % | 5.00 |
Beta Drugs Ltd | 1,745 Cr. | 1,728 | 2,215/1,258 | 38.1 | 195 | 0.00 % | 27.3 % | 25.8 % | 10.0 |
Bal Pharma Ltd | 150 Cr. | 94.4 | 158/76.3 | 20.8 | 48.6 | 1.27 % | 10.1 % | 9.84 % | 10.0 |
Bafna Pharmaceuticals Ltd | 202 Cr. | 85.4 | 95.0/67.8 | 32.1 | 35.8 | 0.00 % | 8.28 % | 7.61 % | 10.0 |
Astrazeneca Pharma India Ltd | 21,961 Cr. | 8,784 | 10,691/6,220 | 125 | 308 | 0.36 % | 33.4 % | 23.6 % | 2.00 |
Amrutanjan Health Care Ltd | 1,897 Cr. | 656 | 863/544 | 37.3 | 113 | 0.30 % | 22.4 % | 16.5 % | 1.00 |
Alpa Laboratories Ltd | 203 Cr. | 96.2 | 145/90.3 | 10.3 | 86.4 | 0.00 % | 15.0 % | 11.4 % | 10.0 |
Alkem Laboratories Ltd | 56,961 Cr. | 4,764 | 6,440/4,492 | 26.4 | 1,002 | 0.94 % | 20.4 % | 19.4 % | 2.00 |
Alembic Pharmaceuticals Ltd | 18,402 Cr. | 936 | 1,304/725 | 31.1 | 264 | 1.17 % | 13.0 % | 11.4 % | 2.00 |
Albert David Ltd | 456 Cr. | 798 | 1,754/763 | 72.5 | 688 | 0.63 % | 6.45 % | 4.39 % | 10.0 |
Ajanta Pharma Ltd | 32,552 Cr. | 2,606 | 3,486/2,022 | 35.0 | 303 | 1.07 % | 32.4 % | 24.9 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,408 Cr. | 305 | 571/258 | 24.9 | 127 | 1.71 % | 13.1 % | 9.54 % | 2.00 |
Aarti Drugs Limited | 4,521 Cr. | 492 | 635/312 | 25.2 | 136 | 0.20 % | 13.4 % | 13.0 % | 10.0 |
Industry Average | 18,338.28 Cr | 1,166.98 | | 48.22 | 193.59 | 0.33% | 16.63% | 15.27% | 6.18 |